Abstract
The invention relates to methods and compositions comprising the use of Vascular Endothelial Growth Factor inhibitors in the treatment or prevention of joint disorders characterised by hypervascularity, inflammation and/or fibrosis of the joint capsule.
| Original language | English |
|---|---|
| Patent number | WO2024020641 |
| IPC | C07K 16/ 22 A I,A61K 2039/545,A61P 19/02,C07K 2317/76 |
| Priority date | 27/07/22 |
| Filing date | 27/07/23 |
| Publication status | Published - 1 Feb 2024 |